BioSpace News Archive

On March 5 , U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and

ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”) (TSX:ADVZ), today announced it signed a definitive agreement to acquire the rights to a portfolio of alprostadil products in 10 European Union countries, as well as the United Kingdom, Russia, Ukraine and Brazil, from UCB S.A.

Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today the presentation of multiple posters at the 37th Annual Miami Breast Cancer Conference

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the Genesis RMN® System for the robotic navigation of magnetic ablation catheters to treat heart rhythm disorders.

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols, today announced that it has received total gross proceeds of $3,510,630.00 during the period from February 28, 2020

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that The Silicon Review Publication (“Silicon Review”) will feature Tauriga Sciences Inc. on its list of the 50 Best Companies to Watch 2020.

The Georgia Dental Association Foundation for Oral Health has launched “Healthy Mouth, Healthy Me!,” a new effort to educate Georgians about the connection between dental health and overall health.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of an inducement equity award to a newly hired employee.

Sparta Science, the Silicon Valley company that applies data and technology in pursuit of human resilience, today announced a $16 million Series B funding round led by GSR Ventures U.S., a private investment firm primarily focused on early-stage companies in the United States developing AI-enabled healthcare technology, enterprise software, and consumer platforms.

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), today announced that it intends to redeem all of its outstanding 15% unsecured debentures issued November 8, 2019 (the “Debentures”) at a price equal to 110% of the principal amount of the Debentures (the “Redemption Price”).